Mariangela DE MASI

Dr. Mariangela DE MASI

Hôpitaux Universitaires de Marseille, Marseille, Provence-Alpes-Côte d’Azur, France
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Radiology
Verified
Journal Article
Closed access
OMOlivier Meyrignac
Olivier Meyrignac
LBLaurence Bal
Laurence Bal
CZCharline Zadro
Charline Zadro
AVAdrien Vavasseur
Adrien Vavasseur
ASAnou Sewonu
Anou Sewonu
RMRamiro Moreno
Ramiro Moreno
A regression model incorporating aneurysm lumen volume and wall shear stress was better than maximal diameter to predict growth of abdominal aortic aneurysms smaller than 50 mm. Background Despite known limitations, the decision to operate on abdominal aortic aneurysm (AAA) is primarily on the basis of measurement of maximal aneurysm diameter. Purpose To identify volumetri...

6 August 2021 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
MGMARINE GAUDRY
MARINE GAUDRY
APAlizée Porto
Alizée Porto
CGCarine Guivier-Curien
Carine Guivier-Curien
ABArnaud Blanchard
Arnaud Blanchard
LBLaurence Bal
Laurence Bal
PPPhilippe Piquet
Philippe Piquet
: OBJECTIVES: We investigated the anatomical evolution of residual aortic dissection after type A repair and factors associated with poor prognosis at a high-volume aortic centre. METHODS: Between 2017 and 2019, all type A aortic dissections were included for prospective follow-up. Patients without follow-up computed tomography (CT) scan available for radiological analysis and patients without residual aortic dissection were excluded from this study. The primary end point was a composite end point defined as dissection-related events including aneurysmal evolution (increased diameter > 5 mm/year), aortic reintervention for malperfusion syndrome, aortic diameter >55 mm, rapid aortic growth >10 mm/year or aortic rupture and death. The secondary end points were risk factors for dissection-related events and reintervention analysis. All immediate and last postoperative CT scans were analysed. RESULTS: Among 104 patients, after a mean follow-up of 20.4 months (8–41), the risk of dissection-related events was 46.1% (48/104) and the risk of distal reintervention was 17.3% (18/104). Marfan syndrome (P < 0.01), aortic bicuspid valve (P = 0.038), innominate artery debranching (P = 0.025), short aortic cross-clamp time (P = 0.011), initial aortic diameter >40 mm (P < 0.01) and absence of resection of the primary entry tear (P = 0.015) were associated with an increased risk of dissection-related events or reintervention during follow-up. CONCLUSIONS: Residual aortic dissection is a serious disease requiring close follow-up at an expert centre. This study shows higher reintervention and aneurysmal development rates than currently published. To improve long-term outcomes, the early demographic and anatomic poor prognostic factors identified may be used for more aggressive treatment at an early phase.

18 March 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
APalizee porto
alizee porto
VOVirgile Omnes
Virgile Omnes
MBMichel A. Bartoli
Michel A. Bartoli
RARon Azogui
Ron Azogui
NRNoémie Resseguier
Noémie Resseguier
MGMARINE GAUDRY
MARINE GAUDRY
Background After a type A aortic dissection repair, a patent false lumen in the descending aorta is the most common situation encountered, and is a well-known risk factor for aortic growth, reinterventions and mortality. The aim of this study was to analyze the long-term results of residual aortic dissection (RAD) at a high-volume aortic center with prospective follow-up. Methods In this prospective single-center study, all patients operated for type A aortic dissection between January 2017 and December 2022 were included. Patients without postoperative computed tomography scans or during follow-up at our center, and patients without RAD were excluded. The primary endpoint was all-cause mortality during follow-up for patients with RAD. The secondary endpoints were perioperative mortality, rate of distal aneurysmal evolution, location of distal aneurysmal evolution, rate of distal reinterventions, outcomes of distal reinterventions, and aortic-related death during follow-up. Results In total, 200 survivors of RAD comprised the study group. After a mean follow-up of 27.2 months (1–66), eight patients (4.0%) died and 107 (53.5%) had an aneurysmal progression. The rate of distal reintervention was 19.5% (39/200), for malperfusion syndrome in seven cases (3.5%) and aneurysmal evolution in 32 cases (16.0%). Most reinterventions occurred during the first 2 years (82.1%). Twenty-seven patients were treated for an aneurysmal evolution of RAD including aortic arch with hybrid repair in 21 cases and branched aortic arch endoprosthesis in six cases. In the hybrid repair group, there was no death, and the rate of morbidity was 28.6% (6/21) (one minor stroke, one pulmonary complication, one recurrent paralysis with complete recovery and three major bleeding events). In the branched endograft group, there was no death, no stroke, and no paraplegia. There was one case (16.7%) of carotid dissection. Complete aortic remodeling or complete FL thrombosis on the thoracic aorta was found in 18 cases (85.7%) and in five cases (83.3%) in the hybrid and branched endograft groups, respectively. Conclusions: Despite a critical course in most cases of RAD, with a high rate of aneurysmal evolution and reintervention, the long-term mortality rate remains low with a close follow-up and a multidisciplinary management in an expert center.

1 November 2005 in Vascular
Verified
Journal Article
Closed access
JAJean-Noël Albertini
Jean-Noël Albertini
Mariangela DE MASIMariangela DE MASI
Mariangela DE MASI
JMJan Macierewicz
Jan Macierewicz
RIRedouane El Idrissi
Redouane El Idrissi
BHBrian R. Hopkinson
Brian R. Hopkinson
ABAlain Branchereau
Alain Branchereau
Neck angulation (NA) is an important risk factor for type 1 proximal endoleaks following stenting of abdominal aortic aneurysms. The Aorfix (Lombard Medical, Oxon, UK) is a new flexible stent graft designed to overcome this issue. The aim of this study was to compare the endoleak flow rate (EFR) in relation to NA between the Aorfix and other manufactured stent grafts. A flow model with silicone proximal and distal necks was used. EFRs corresponding to 10 neck angles between 0 and 70° were measured. Eight stent grafts were tested: Aorfix, Ancure (Guidant, Indianapolis, IN), Powerlink (Endologix, Irvine, CA), AneuRx (Medtronic, Sunnyvale, CA), Excluder (W.L. Gore & Associates, Flagstaff, AZ), Zenith and Zenith-Flex (Cook Inc., Bloomington, IN), and Lifepath (Edwards Lifesciences, Irvine, CA). For all stent grafts except the Aorfix, the EFR was greater than at baseline for NA ≥ 30° ( p < .01). The EFR at NA ≥ 30° was lower with the Aorfix compared with the other stent grafts ( p < .01). NA had no influence on the EFR with the Aorfix. The Aorfix may decrease the incidence of proximal type 1 endoleak in patients with a severely angulated aortic neck.

1 October 2019 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
MVMichael Vaillant
Michael Vaillant
PBPierre-Antoine Barral
Pierre-Antoine Barral
JMJulien Mancini
Julien Mancini
Mariangela DE MASIMariangela DE MASI
Mariangela DE MASI
LBLaurence Bal
Laurence Bal
MGMARINE GAUDRY
MARINE GAUDRY

1 May 2002 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
CSC. De Simone
C. De Simone
AGA. R. Giampetruzzi
A. R. Giampetruzzi
CGC. Guerriero
C. Guerriero
Mariangela DE MASIMariangela DE MASI
Mariangela DE MASI
PAPaolo Amerio
Paolo Amerio
GCG. Cina
G. Cina